Epstein Secrets

L EMAIL] - FBI Public Affairs News Briefing Friday, October 23, 2020 To: [email protected] Sent: October 23, 2020 6:26 AM (UTC-04:00) Mobile version and searchable archives available at tbi.bulletinintellioence.com. TO : THE DIRECTOR AND SENIOR STAFF DATE : FRIDAY, OCTOBER 23, 20

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AE (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust

ubject: [EXTERNAL EMAIL] - FBI Public Affairs 2020 Date: Fri, 23 Oct 2020 10:26:13 +0000 c Importan e: Normal News Briefing Friday, October 23, Mobile version and searchable archives available at fbi.bulletinintelligence.com. 'FBI News Briefing TO: THE DIRECTOR AND SENIOR STAFF DATE: FRIDAY, OCTOB

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AP (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust

0) Eastern Time (US & Canada) To: [email protected] Subject: [EXTERNAL EMAIL] - FBI Public Affairs News Briefing Tuesday, July 28, 2020 Mobile version and searchable archives available at fbi.bulletinintelligence.com. ;`.7B1 News Briefing TO: THE DIRECTOR AND SENIOR STAFF DATE: TUESDAY, JU

promise, mRNA technology has never been used to make a successful vaccine before." USA Today (7/27, Weintraub, 10.31M), the Washington Times (7/27, Neergaard, 492K), CQ Roll Call (7/27, Siddons, 154K) and New York Times (7/27, Grady, 18.61M), among other news outlets, also report the story. CNBC (7/27,